Telmisartan

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

A nonpeptide angiotensin II receptor antagonist which selectively and insurmountably inhibits the angiotensin II AT1 receptor subtype (Ki = 3.7 nM) a partial agonist of PPAR&gamma, activating the receptor to 25-30% of that produced by the full

A nonpeptide angiotensin II receptor antagonist which selectively and insurmountably inhibits the angiotensin II AT1 receptor subtype (Ki = 3.7 nM) a partial agonist of PPAR&gamma, activating the receptor to 25-30% of that produced by the full

A nonpeptide angiotensin II receptor antagonist which selectively and insurmountably inhibits the angiotensin II AT1 receptor subtype (Ki = 3.7 nM) a partial agonist of PPAR&gamma, activating the receptor to 25-30% of that produced by the full

A labeled Telmisartan, which is an angiotensin II receptor antagonist.

Available in 10 or 20 &microm.